| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/25/2008 | US20080318293 Sulfotransferase Inhibitors |
| 12/25/2008 | US20080317887 Compositions and Methods for Treating and Preventing Migrainous Headaches and Associated Symptoms |
| 12/25/2008 | US20080317885 Compositions and Methods for Treating and Preventing Inflammatory and/or Degenerative Processes in Humans and Other Animals |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
| 12/25/2008 | US20080317707 Pegylated interleukin-10 |
| 12/24/2008 | WO2008157365A2 Vinylazacycloalkanes for treating neuropathic pain |
| 12/24/2008 | WO2008156780A1 Particulates of a crth2 antagonist |
| 12/24/2008 | WO2008156646A1 Topical composition for treating pain |
| 12/24/2008 | WO2008156645A2 Pharmaceutical compositions and uses |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155520A2 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 12/24/2008 | WO2008155140A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/24/2008 | WO2008155035A2 Oxazolidinones for the treatment and prophylaxis of sepsis |
| 12/24/2008 | WO2008154898A2 Preparation for the treatment of equine laminitis |
| 12/24/2008 | WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 12/24/2008 | WO2008107543A3 Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof |
| 12/24/2008 | WO2008060372A3 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 12/24/2008 | WO2008057856A3 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 12/24/2008 | WO2008048866A3 Bicyclic heteroaromatic compounds |
| 12/24/2008 | EP2006681A1 Rheumatoid arthritis test method and treating method |
| 12/24/2008 | EP2004693A2 Compositions and methods of use for antibodies of c-met |
| 12/24/2008 | EP2004692A1 Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 12/24/2008 | EP2004675A1 Combination of cytokine and cytokine receptor for altering immune system functioning |
| 12/24/2008 | EP2004656A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
| 12/24/2008 | EP2004649A2 Phenolic hydrazone macrophage migration inhibitory factor inhibitors |
| 12/24/2008 | EP2004645A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 12/24/2008 | EP2004631A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases |
| 12/24/2008 | EP2004602A1 Salts with crth2 antagonist activity |
| 12/24/2008 | EP2004597A2 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 12/24/2008 | EP2004596A2 Compositions useful as inhibitors of voltage-gated sodium channels |
| 12/24/2008 | EP2004236A2 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| 12/24/2008 | EP2004203A2 Formulations of low dose diclofenac and beta-cyclodextrin |
| 12/24/2008 | EP2004192A2 Modified macrophage migration inhibitory factor inhibitors |
| 12/24/2008 | EP2004190A1 Non-codeine opioid analgesic process and formulations |
| 12/24/2008 | EP2004149A1 Pharmaceutical compositions containing leflunomid |
| 12/24/2008 | EP1627866B1 Carboxylic acid compound and medicine containing the same |
| 12/24/2008 | EP1620102B1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/24/2008 | EP1531819B1 USE OF I kappa B KINASE INHIBITORS FOR THE TREATMENT OF PAIN |
| 12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 12/24/2008 | EP1341786B1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | CN101331124A Novel vanilloid receptor ligands and their use for producing medicaments |
| 12/24/2008 | CN101331118A Pyrazoles useful in the treatment of inflammation |
| 12/24/2008 | CN101328166A 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor |
| 12/24/2008 | CN101328150A 新的苯并咪唑衍生物 New benzimidazole derivatives |
| 12/24/2008 | CN101328135A Carbonyl phenyl propanoic acid derivative compounds |
| 12/24/2008 | CN101327313A Oral medication for treating epigastric pain |
| 12/24/2008 | CN101327305A Chinese medicine for treating appendicitis and preparation method thereof |
| 12/24/2008 | CN101327302A Chuan Xiong Tea soft capsule and method for preparing the same |
| 12/24/2008 | CN101327295A Chinese medicine for releasing toxicity and relieving inflammation |
| 12/24/2008 | CN101327288A Method for preparing Liaoyuanqili super fine powder |
| 12/24/2008 | CN101327287A Method for preparing Liaoyuanqili ultramicro powder |
| 12/24/2008 | CN101327280A Chinese medicine for treating paralysis |
| 12/24/2008 | CN101327278A Sang Ju heat-cleaning fire toxin-releasing king tea composition |
| 12/24/2008 | CN101327277A Heat-cleaning fire toxin-releasing king tea composition |
| 12/24/2008 | CN101327263A Use of stasis-dispersing medicament composition in preparing medicament for treating abdominal cavity adhesion peritonitis |
| 12/24/2008 | CN101327257A Chinese medicine preparation for treating rheumatic arthritis and rheumatoid arthritis |
| 12/24/2008 | CN101327256A Medicament for treating rheumatism and rheumatoid and preparation thereof |
| 12/24/2008 | CN101327250A Suppositorium for treating fever in children and preparation method thereof |
| 12/24/2008 | CN101327242A Prepared honeysuckle, processing method thereof, and its uses in preparing drink or medicament for clearing heat and cooling blood, activating blood and resolving stasis |
| 12/24/2008 | CN101327235A Use of pseudo-ginseng saponins for treating septicemia |
| 12/24/2008 | CN101327234A Rheumatalgia-relieving acetanilid |
| 12/24/2008 | CN101327219A Prednisolone acetate in situ forming eye gel |
| 12/24/2008 | CN101327197A Sustained release drug delivery devices |
| 12/24/2008 | CN101327193A Lornoxicam freeze-dried injection and preparation method thereof |
| 12/24/2008 | CN101327010A Method for preparing amber ginseng |
| 12/24/2008 | CN101326945A Jujube chestnut leaf tea |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444835C Tendon-relaxing blood circulation-activating capsule and preparation process thereof |
| 12/24/2008 | CN100444834C Effervescence tablet for treating wind-cold type cold and preparation process thereof |
| 12/24/2008 | CN100444829C Freeze-dry snow lotus powder for venous injection and its preparation method |
| 12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof |
| 12/24/2008 | CA2690172A1 Particulates of a crth2 antagonist |
| 12/24/2008 | CA2689393A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/23/2008 | US7468380 Nitrogen-containing aromatic derivatives |
| 12/23/2008 | US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 12/23/2008 | US7468370 [1,7]naphthyridines as PDE4 inhibitors |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468189 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/18/2008 | WO2008154251A2 C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| 12/18/2008 | WO2008154136A1 Compositions and methods for modulating inflammation using fluoroquinolones |
| 12/18/2008 | WO2008153882A1 Benefit agent containing delivery particle |
| 12/18/2008 | WO2008153426A1 Anti-inflammatory composition and use thereof |
| 12/18/2008 | WO2008153394A2 Novel anti-inflammatory pro-drugs |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |